Storyline
New models reveal tumor-stroma interactions and chemotherapy tolerance in cancer
Recent studies using advanced models have shed light on tumor microenvironment dynamics and chemotherapy resistance.
Published 2026-07-08 16:08 UTCUpdated 2026-07-09 11:08 UTC
Current brief openSource links open
This current storyline is open here with summary, metadata, source links, continuity context, and full evidence. Paid is for compare-over-time, alerts, exports, and workflow.
No card needed for the free brief.
Evidence trail (top sources)
top sources (1 domains)domains are deduped. counts indicate coverage, not truth.1 top source shown
limited source diversity in top sources
Overview
Recent studies using advanced models have shed light on tumor microenvironment dynamics and chemotherapy resistance.
Score total
0.96
Momentum 24h
3
Posts
3
Origins
1
Source types
1
Duplicate ratio
0%
Why now
- New in ovo and organoid models enable rapid, patient-relevant tumor microenvironment studies.
- Single-cell and CRISPR screening technologies uncover regulators of cancer cell plasticity.
- Insights into persister clones inform strategies to overcome chemoresistance and metastatic relapse.
Why it matters
- Understanding tumor-stroma interactions can identify new therapeutic targets in cancer.
- Revealing mechanisms of chemotherapy tolerance helps address minimal residual disease and relapse.
- Models preserving tumor heterogeneity improve translational relevance of preclinical studies.
Continuity snapshot
- Trend status: insufficient_history.
- Continuity stage: seed.
- Current status: open.
- 3 current source-linked posts are attached to this storyline.
All evidence
All evidence
Modeling pancreatic cancer tumor stroma co-evolution in an in ovo model
bioRxiv (all subjects) · biorxiv.org · 2026-07-09 11:08 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 1Origin domains: 1Duplicates: -
Showing 1 / 0
Top publishers (this list)
- bioRxiv (all subjects) (1)
Top origin domains (this list)
- biorxiv.org (1)